Publications by authors named "G Finzi"

Simultaneous activation of the incretin G-protein-coupled receptors (GPCRs) via unimolecular dual-receptor agonists (UDRA) has emerged as a new therapeutic approach for type 2 diabetes. Recent studies also advocate triple agonism with molecules also capable of binding the glucagon receptor. In this scoping review, we discuss the cellular mechanisms of action (MOA) underlying the actions of these novel and therapeutically important classes of peptide receptor agonists.

View Article and Find Full Text PDF

Three-dimensional (3D) chromatin organization has a key role in defining the transcription program of cells during development. Its alteration is the cause of gene expression changes responsible for several diseases. Thus, we need new tools to study this aspect of gene expression regulation.

View Article and Find Full Text PDF

Amphicrine carcinomas are epithelial neoplasms composed of cells with co-existing exocrine-neuroendocrine phenotype and are challenging lesions from both diagnostic and therapeutic perspectives.Here, we report the case of a 63-year-old male patient with a gastric nodule that was endoscopically biopsied, revealing histological features of a type 3 well-differentiated gastric neuroendocrine tumor (NET). At imaging, the lesion was single and limited to the stomach, but did not present Octreotide uptake, despite SSTR2A immunohistochemical expression.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists studied how cells change during early development and wanted to see if similar changes happen in cancer cells, specifically in a type of pediatric cancer called Ewing sarcoma.
  • They found that a protein called EWS-FLI1 creates special connections in the cell’s DNA that help the cancer cells grow.
  • When they took away EWS-FLI1, the DNA connections changed back to a more normal state, which might allow the cells to behave more like healthy stem cells.
View Article and Find Full Text PDF

Aims: Several reports indicate that diabetes determines an increased mortality risk in patients with coronavirus disease 19 (COVID-19) and a good glycaemic control appears to be associated with more favourable outcomes. Evidence also supports that COVID-19 pneumonia only accounts for a part of COVID-19 related deaths. This disease is indeed characterised by abnormal inflammatory response and vascular dysfunction, leading to the involvement and failure of different systems, including severe acute respiratory distress syndrome, coagulopathy, myocardial damage and renal failure.

View Article and Find Full Text PDF